Peptide Drug Conjugates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Lutetium, Melflufen, ANG1005, BT1718, CBX-12, Other Pipeline Products), By Type (Therapeutic, Diagnostic) By Region and Competition
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationPeptide Drug Conjugates Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Lutetium, Melflufen, ANG1005, BT1718, CBX-12, Other Pipeline Products), By Type (Therapeutic, Diagnostic) By Region and Competition
| Forecast Period | 2024-2028 |
| Market Size (2022) | USD 600.01 million |
| CAGR (2023-2028) | 13.32% |
| Fastest Growing Segment | Therapeutic |
| Largest Market | North America |
Market Overview
Key Market Drivers
Rising Incidence of Cancer
Advancements in Drug Delivery Technologies
Increasing Investment in Research and Development
Key Market Challenges
High Development Costs
Limited Clinical Data
Competition from Other Targeted Therapies
Key Market Trends
The increasing focus on targeted therapies
Expanding Pipeline of Peptide-Based Drugs
Segmental Insights
Product Insights
Type Insights
Regional Insights
Recent Developments
- In November 2022, Exelixis, Inc. and Cybrexa Therapeutics announcedtheir cooperation agreement , giving Exelixis the opportunity to purchaseCBX-12, a first-in-class peptide-drug conjugate (PDC). It is anticipated thatthis project will increase the clinical pipeline for the targeted medicationtherapy.
- In June 2019, PDC, a macrocyclic peptide with diagnostic andtherapeutic, was developed through apartnership between Novartis AG and PeptiDream Inc.
Key Market Players
- Novartis AG.
- BicycleTherapeutics PLC
- AstraZenecaPLC
- CybrexaTherapeutics Inc
- OncopeptidesInc.
- AngiochemInc.
- InnovasiumSoricimed Biopharma
- TheratechnologiesInc.
- CoherentBiopharma Co. Ltd
- WuxiSTA
| By Product | By Type | By Region |
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy